2YW-97737-74008 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-30
Dose 1 — Pfizer-BioNTech
2021-03-31
Registered in v-safe
2021-03-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-01
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-04-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-05
Dose 2 — Pfizer-BioNTech
2021-05-05
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-11-05
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-27
Dose 3 — Pfizer-BioNTech
2021-12-03
Survey response — days 1–6 daily, dose 3
MedDRA: Fatigue, Pain in extremity, Pyrexia — Feeling: Good · Fatigue or tiredness

Free text: The only symptoms I had with this booster were fatigue & slight fever the following day & arm soreness. Nothing else.

MedDRA releases: 2024-11 · check-in free text available
2021-12-05
Survey response — day 7, dose 3
MedDRA: Eye irritation, Ocular hyperaemia — Feeling: Good

Free text: Red irritated eyes for 2 days

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-30	Pfizer-BioNTech
2	2021-05-05	Pfizer-BioNTech
3	2021-11-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-04-01	priority 2/3

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-03

Systemic reaction (other): The only symptoms I had with this booster were fatigue & slight fever the following day & arm soreness. Nothing else.

Release 10 — day 7, dose 3

2021-12-05

Systemic reaction (other): Red irritated eyes for 2 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Eye irritation	·	·	✓
SRO	Fatigue	·	·	✓
SRO	Ocular hyperaemia	·	·	✓
SRO	Pain in extremity	·	·	✓
SRO	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release